- Home
- BODI vs ABVC Comparison
BODI vs ABVC Comparison
Compare BODI & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- ABVC
- Stock Information
- Founded
- BODI 1998
- ABVC 2015
- Country
- BODI United States
- ABVC United States
- Employees
- BODI N/A
- ABVC N/A
- Industry
- BODI Industrial Machinery/Components
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- ABVC Health Care
- Exchange
- BODI Nasdaq
- ABVC Nasdaq
- Market Cap
- BODI 25.4M
- ABVC 22.1M
- IPO Year
- BODI N/A
- ABVC N/A
- Fundamental
- Price
- BODI $3.80
- ABVC $2.19
- Analyst Decision
- BODI Strong Buy
- ABVC
- Analyst Count
- BODI 3
- ABVC 0
- Target Price
- BODI $10.67
- ABVC N/A
- AVG Volume (30 Days)
- BODI 90.2K
- ABVC 312.1K
- Earning Date
- BODI 08-05-2025
- ABVC 08-13-2025
- Dividend Yield
- BODI N/A
- ABVC N/A
- EPS Growth
- BODI N/A
- ABVC N/A
- EPS
- BODI N/A
- ABVC N/A
- Revenue
- BODI $371,113,000.00
- ABVC $508,383.00
- Revenue This Year
- BODI N/A
- ABVC $735.18
- Revenue Next Year
- BODI N/A
- ABVC N/A
- P/E Ratio
- BODI N/A
- ABVC N/A
- Revenue Growth
- BODI N/A
- ABVC 1904.43
- 52 Week Low
- BODI $3.38
- ABVC $0.40
- 52 Week High
- BODI $9.40
- ABVC $2.29
- Technical
- Relative Strength Index (RSI)
- BODI 47.34
- ABVC 70.75
- Support Level
- BODI $3.51
- ABVC $1.84
- Resistance Level
- BODI $3.86
- ABVC $2.29
- Average True Range (ATR)
- BODI 0.43
- ABVC 0.16
- MACD
- BODI 0.03
- ABVC 0.03
- Stochastic Oscillator
- BODI 15.38
- ABVC 87.65
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.